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Objective. To determine perceived barriers to and facilitators of a career in rheumatology research, examine factors
leading rheumatologists to leave an academic research career, and solicit ways to best support young physician-
scientists.
Methods. A web-based survey was conducted among the domestic American College of Rheumatology (ACR) member-
ship from January through March 2014. Inclusion criteria were ACR membership and an available e-mail address.
Non-rheumatologists were excluded. The survey assessed demographics, research participation, barriers to and facili-
tators of a career in research, reasons for leaving a research career (when applicable), and ways in which the ACR
could support junior investigators. Content analysis was used to extract relevant themes.
Results. Among 5,448 domestic ACR members, 502 responses were obtained (9.2% response rate). After exclusions (38
incomplete, 2 duplicates, 32 non-rheumatologists), 430 responses were analyzed. Participants included fellows, young
investigators, established investigators, mentors, clinicians, and those who previously pursued a research career but
have chosen a different career path. Funding and mentoring were the most highly ranked barriers and facilitators.
Protection from clinical and administrative duties, institutional support, and personal characteristics such as resil-
ience and persistence were also ranked highly. The most commonly cited reasons for leaving an academic research
career were difficulty obtaining funding and lack of department or division support.
Conclusion. This is the first study to examine barriers to and facilitators of a career in rheumatology research from
the perspectives of diverse groups of rheumatologists. Knowledge of such barriers and facilitators may assist in
designing interventions to support investigators during vulnerable points in their career development.
It is the progressive decline in the number of new entries that
constitutes the danger to the survival of the species in the num-
bers and quality needed to maximize the rate of progress against
the serious diseases of mankind.
James B. Wyngaarden, MD (1)
INTRODUCTION
In 1979, James B. Wyngaarden, MD, future director of the
National Institutes of Health (NIH), called the physician-
scientist an “endangered species” as he noted rapid de-
clines over the previous two decades in the number of
clinicians also trained in research methodology and
simultaneously acting as a physician and “serious scien-
tist” (1). While the American medical system has evolved
and funding sources have risen and fallen in the decades
following Dr. Wyngaarden’s paper, the same concern
about the small pool of physician-scientists remains.
Francis Collins, MD, current director of the NIH, recently
commissioned a Physician-Scientist Workforce Working
Group (PSWWG) with “analyzing the current composition
and size of the physician-scientist biomedical workforce
and making recommendations for actions that NIH should
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take to help sustain and strengthen a robust and diverse
PSW.” The executive summary, published in June 2014,
reports a shrinking NIH budget compared to previous lev-
els of funding, an aging physician-scientist workforce, and
a decline in the number of new physician-scientists enter-
ing the workforce (2). Additionally, a high rate of attrition
exists among those initially choosing a research career,
with significant dropout between receipt of an NIH career
development award (K series) and obtaining an R01-level
project grant (2).
Physician-scientists in rheumatology have dramatically
improved our understanding of rheumatic diseases, directly
propelling the unprecedented growth of effective therapies
such as biologic agents in the past 15 years. The aging
workforce and smaller number of physician-scientists is
particularly a concern in rheumatology (3). Continued
understanding of rheumatic diseases and generation of
novel therapeutics could thus be in jeopardy. Therefore, the
development and cultivation of young rheumatology inves-
tigators is critical to the future of rheumatology.
While research and salary support for clinician-
investigators is clearly a concern, the NIH PSWWG notes
that other issues beyond funding also contribute. How-
ever, the specific barriers and facilitators for maintaining a
career in research remain unclear. If such barriers and
facilitators are identified, strategies may be developed to
target obstacles and better support investigators, particu-
larly young investigators launching their career.
The objectives of this study were to 1) determine the
perceived barriers to and facilitators of a career in rheuma-
tology research, 2) examine factors leading to rheumatolo-
gists leaving a career in research, and 3) determine how
the American College of Rheumatology (ACR) can best
support young investigators through the early part of their
career.
SUBJECTS AND METHODS
Participants. We conducted a survey among the ACR
membership living in the US. Inclusion criteria consisted
of current or previous fellowship in rheumatology, mem-
bership in the ACR, and an available e-mail address. Non-
rheumatologist members of the ACR were excluded. This
study was approved by the University of Pennsylvania
Institutional Review Board.
Survey instrument. The survey instrument was devel-
oped through the use of a Delphi method (see Supple-
mentary Figure 1, available in the online version of this
article at http://onlinelibrary.wiley.com/doi/10.1002/acr.
22569/abstract). The full survey is available in Supplemen-
tary Appendix A (available in the online version of this
article at http://onlinelibrary.wiley.com/doi/10.1002/acr.
22569/abstract). The instrument included items reflecting
demographics, including age, sex, underrepresented minor-
ity status, current position and job type (e.g., academics, pri-
vate practice, industry), academic rank if applicable, and
year entering rheumatology fellowship. Branching logic was
used to identify current investigators, research mentors, and
rheumatologists who have left research careers. Reasons for
leaving a career in research were solicited both via a list of
options and through free-text comments. Next, participants
were asked to rank the top 10 barriers to and top 10 facilita-
tors of a career in rheumatology research (ranked from
1–10). Participants were asked to select useful formats for
providing support to young investigators (e.g., workshops,
webinars, etc.). Free-text responses solicited ways in which
the ACR can best support young investigators and any addi-
tional comments.
Significance & Innovations
 The physician-scientist workforce is aging, fewer
young investigators are entering the workforce,
and maintaining a career in research is challeng-
ing. To our knowledge, this is the first study to
examine barriers and facilitators of sustaining a
career in rheumatology research and reasons for
leaving a career in rheumatology research.
 While funding is a major barrier to (or facilitator
of) a career in research, mentoring is critical to
the development and sustenance of a career in
rheumatology research.
 Protected research time, protection from clinical
and administrative duties, personal characteris-
tics, passion for the job, and institutional sup-
port were also highly ranked facilitators of a
successful career in rheumatology research.
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Survey administration. The surveys were sent on Janu-
ary 15, 2014 and closed on March 15, 2014, with one
reminder e-mail on February 12, 2014. REDCap software
was used to administer the surveys anonymously via an
e-mail with a link to a web-based survey. Participants
completing the survey were eligible to enter a drawing for
complimentary registration for the 2014 ACR/ARHP
(Association of Rheumatology Health Professionals)
Annual Meeting in Boston, Massachusetts.
Statistical analysis. After excluding incomplete sur-
veys and duplicates, demographics were summarized.
Barriers and facilitators were categorized as important if
ranked as 1, 2, or 3 of 10. The proportion of “important”
ratings was reported for each barrier and facilitator. We
then examined whether individual categories of partici-
pants (young investigators, mentors, fellows, and those
who left a career in research) rated these barriers and facil-
itators differently from the remainder of the participants
using a chi-square test.
Content analysis (4) was performed for free-text com-
ments for 1) reasons for leaving a research career, 2) ways
in which the ACR can support young investigators, and 3)
general comments. Two coders (AO and YJ) developed a
coding list (see Supplementary Appendix B, available in
the online version of this article at http://onlinelibrary.
wiley.com/doi/10.1002/acr.22569/abstract) and iteratively
applied these codes to the comments. Discrepancies were
resolved through discussion with a third coder (UEM).
Percent agreement between AO and YJ was 98%. Themes
that emerged from the qualitative responses were dis-
cussed among the study team and are shown below.
RESULTS
Survey participants. Among 5,448 domestic ACR mem-
bers, 502 responses were obtained within the 8-week time-
frame (9.2% response rate). Among the participants, 32
were excluded because they were not rheumatologists, 38
were incomplete, and 2 duplicates were identified and
excluded. The final number of responses for analysis was
430. This included 309 adult rheumatologists, 62 pediat-
ric rheumatologists, 42 adult rheumatology fellows, and
17 pediatric rheumatology fellows. Demographics of the
participants are shown in Table 1. The majority of partici-
pants (71%) were working in academic medical centers.
Among those with academic affiliations, 34 were instruc-
tors (or equivalent), 102 were assistant professors, 58 were
associate professors, and 89 were professors.
Among the survey participants, 171 (40%) reported
actively pursuing a career in research (147 faculty, 24 fel-
lows). Of these, 64% were women. Types of research are
shown in Table 1. Additionally, 52% of those actively pur-
suing research considered themselves a young investigator
(defined as within 6 years of completing fellowship), and
44% indicated they were a mentor to a young investigator.
Although the median percent effort dedicated to research
was 15% (interquartile range [IQR] 2–70%) among all par-
ticipants, young investigators reported a median percent
effort dedicated to research of 75% (IQR 70–80%).
Participants who have left a research career. Ninety-
seven participants (23%) indicated that they had previously
pursued a career in research, but decided to switch career
paths. This career change occurred a median of 10 years
prior (IQR 3–20 years), with a median transition point 7
years after fellowship (IQR 2–14 years) (see Supplementary
Figure 2, available in the online version of this article at
http://onlinelibrary.wiley.com/doi/10.1002/acr.22569/abstract).
Previous research types and current positions are shown in
Table 2. Approximately half of the participants were
women. The most commonly reported reasons for leaving
research were difficulty obtaining funding and lack of
department or division support. In free-text comments
(n5 51), participants cited additional reasons for leaving
research, including great clinical burden and insufficient
protected time to be successful in research endeavors, finan-
cial factors (e.g., difficulty supporting family financially, dif-
ficulty covering loans with low salary), lack of mentorship,
an unsupportive environment or institution, and personal
reasons (e.g., new opportunities in administration, teaching,
and/or clinical care; need to move to a new geographic area
without opportunities for research; increasing age; need for
increased job security; and fear of having to move if not suc-
cessful in obtaining funding or achieving tenure):
“I had to see more patients to support my salary in academic
medicine. This made it difficult to pursue research. The uni-
versity used to pay [a] large part of our salary, but they
stopped doing that, requiring rheumatologists to see patients
to generate their income.”
“I had to move for family reasons. I would have preferred
moving to academia in the geographic region of interest, but
there was not a realistic amount of protected time available in
the jobs I considered to be able to conduct research. Also,
because of the number of years spent with inadequate com-
pensation, I needed higher pay to support putting the kids
through college.”
When asked what would have kept these rheumatologists
in research, the most common responses included
increased protected time and availability of internal grant
funding mechanisms. Analysis of free-text comments
revealed additional issues, including the need for job
security, improved mentorship, less politics, and more
supportive institutional environments:
“Job security was what drove me out of academics. I was at a
high-powered academic center and I loved it, but I calculated
my odds of getting tenure at about 50%. R01 funding at
NIAID [National Institute of Allergy and Infectious Diseases]
at that time was under 10% and the rule for tenure at my
institution, as I understood it, was 2 grants. MANY junior fac-
ulty were not getting tenure. My kids would have been in the
middle of high school when my time for a tenure decision
arrived, and I decided not to risk having to move them.”
Barriers and facilitators. Barriers to and facilitators of
a career in research are outlined in Figures 1 and 2,
respectively. The most highly ranked barrier to and facili-
tator of a career in research was funding. This was of sig-
nificantly greater concern to young investigators than to
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Table 1. Demographics of survey participants with complete data (n5430)*
Value
Current position
Adult rheumatologist 309 (72)
Pediatric rheumatologist 62 (14)
Adult fellow 42 (10)
Pediatric fellow 17 (4)
Place of employment
Academic medical center 306 (71)
Clinical practice 97 (23)
Industry 20 (5)
Government 3 (1)
Retired 4 (1)
Academic appointment
Instructor or other junior faculty 34 (8)
Assistant professor 102 (24)
Associate professor 58 (13)
Professor 89 (21)
Other or not applicable 147 (34)
Year completed fellowship, median (IQR) 2005 (1987–2012)
1960–1969 8 (2)
1970–1979 31 (7)
1980–1989 82 (19)
1990–1999 56 (13)
2000–2009 102 (24)
2010–2013 81 (19)
2014–2016 64 (15)
Missing 6 (1)
Female sex 241 (56)
Medical school in the US 318 (74)
Underrepresented minority† 28 (7)
Effort, median (IQR) %‡
Clinical 50 (20–75)
Research 15 (2–70)
Teaching 5 (4–10)
Administrative 5 (0–11)
Successful funding
Foundation fellowship/postdoc award 92 (21)
Foundation career development award 99 (23)
NIH Loan Repayment Program 24 (6)
NIH K series or VA career development award 76 (18)
NIH R01 award 59 (14)
Other NIH awards 71 (17)
Any other grants 141 (33)
Current researcher
Total 171 (40)
Young investigator 88 (20)
Mentor to young investigator 76 (18)
Research effort $50% 134 (31)
Research effort $70% 100 (23)
Type of research§
Clinical 88 (51)
Epidemiology/health services 18 (11)
Translational 99 (58)
Basic science 53 (31)
* Values are the number (percentage) unless indicated otherwise. IQR5 interquartile range; NIH5Na-
tional Institutes of Health; VA5Veterans Affairs.
† An underrepresented minority within rheumatology was defined as African American, Hispanic, or
Native American (i.e., American Indian, Alaska native, and native Hawaiian). This information has not
been collected among American College of Rheumatology members in general. However, among early
career rheumatologists in the Rheumatology Workforce Survey, approximately 9.7% ascribed to similar
categories (3).
‡ Effort estimates exclude fellows.
§ Among those currently engaged in research (n5 171), .1 answer per participant was allowed; there-
fore, the total adds to greater than 100%.
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other participants. After funding, the next most commonly
reported barriers were clinical workload, insufficient pro-
tected time, lower salary, and lack of institutional research
infrastructure. Facilitators of a career in research, aside from
sufficient funding, were protected research time, outstanding
mentors, institutional support, and funding for young inves-
tigators, as well as personal skills or traits such as hard work,
resilience, initiative, persistence, and passion for the job.
We next examined differences in the frequency of barriers
and facilitators reported by subgroups (see Supplementary
Table 1, available in the online version of this article
at http://onlinelibrary.wiley.com/doi/10.1002/acr.22569/
abstract). Beyond funding, participants who had left a
career in research were significantly more likely to report
lack of institutional research infrastructure, lack of access
to key people in the field, lack of diverse mentorship, local
politics or conflict, poor relationship with the division
chief, and lack of a clear career development pathway as
important barriers, and noted formal research training and
ability to establish a niche as important facilitators. Fellows
were more likely to report presentation skills and difficulty
establishing a niche as important barriers.
Evaluation of free-text comments revealed only a few
additional themes. Several participants (n58) indicated
that gender issues still remained a barrier to pursuing a
career in research. Others indicated that the need to care
Table 2. Participants who decided to leave a research career (n5 97)*
Value
Female sex 45 (46)
Years since transition, median (IQR) 10 (3–20)
Year of fellowship completion, median (IQR) 1993 (1983–2005)
Years after fellowship when transition occurred, median (IQR) 7 (2–14)
Current position
Adult rheumatologist 78 (80)
Pediatric rheumatologist 14 (14)
Adult fellow 5 (5)
Pediatric fellow 0 (0)
Place of employment
Academic medical center 52 (54)
Clinical practice 24 (25)
Industry 17 (18)
Government 2 (2)
Retired 2 (2)
Academic appointment (current)
Instructor or other junior faculty 6 (6)
Assistant professor 14 (14)
Associate professor 21 (22)
Professor 22 (23)
Other or not applicable 34 (35)
Previous type of research
Clinical 47 (48)
Epidemiology/health services 8 (8)
Translational 36 (37)
Basic science 49 (51)
Factors contributing to decision to leave
Difficulty obtaining grant funding 55 (57)
Lack of division/department support 51 (53)
Better compensation 38 (39)
Lack of mentorship 38 (39)
Tired of writing grants 33 (34)
Personal reasons† 26 (27)
Desire to spend more time in clinical care 20 (21)
Exciting opportunities in industry 10 (10)
Did not enjoy research work 6 (6)
What would have retained you in a research career?
Provide internal grant funding mechanisms 54 (56)
Increase protected time 50 (52)
Increase income 31 (32)
Increase work flexibility 25 (26)
Provide greater leadership opportunities 25 (26)
Nothing would have incentivized me to stay in academics 9 (9)
* Values are the number (percentage) unless indicated otherwise. IQR5 interquartile range.
† Personal reasons included desire to move geographically (n5 16) or desire to spend more time with
family (n5 15).
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for young children and the inability to allow flexibility in
grants for time off to have children and part-time work
prevented their continuing research careers:
“The majority of ACR leadership seems to be men, while
younger members are more likely to be women. ACR should
also have a program for young women investigators who go
through pregnancy. . .etc.”
“The early investigator definition of 6 years from fellowship com-
pletion disadvantages young women with babies/young kids dur-
ing that timeframe from participating in onsite workshops.”
“I was a classic example of the female academic who falls off
the tenure track.”
“There is no room at the academic table for us lowly clinician
educators or for women who still have to deal with the
numerous micro hits that torpedo our careers.”
“When I was a fellow, male fellows were offered academic
positions with several-year contracts, but female fellows were
offered only 1-year contracts.”
A fear of failure or lack of confidence in abilities was also
reported by 2 participants. Lack of institutional infrastruc-
ture for research and lack of knowledge about the needs of
young investigators on the part of both the division chiefs
and fellowship directors were cited as barriers.
Numerous participants indicated that clinical workload
and administrative duties are a significant burden to
researchers:
“Why does everyone in academia have to do everything
(teach, research, write, see patients)? Academia needs to re-
examine the way things have ‘always’ been done.”
“Keeping junior faculty researchers productive despite the
ever-increasing demands that clinical work places on part-
Figure 1. Barriers to a career in research. Among all survey participants, the most commonly cited barriers are shown for all partici-
pants and then subgroups of participants. The x-axis shows the percentage of participants ranking each item as important (defined as
ranking the item as 1, 2, or 3 of 10). The barriers are split into the following categories: F5 funding; J5 job duties; M5mentoring and
networking; O5 outside influences; I5 institution; P5personal skills and characteristics. Additional barriers and P values for differen-
ces between groups are shown in Supplementary Table 1 (available in the online version of this article at http://onlinelibrary.wiley.
com/doi/10.1002/acr.22569/abstract).
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time clinical faculty, including administrative duties required
for CME [Continuing Medical Education], compliance, ICD-10
[International Statistical Classification of Diseases and Related
Health Problems, Tenth Revision] training, MOC [mainte-
nance of certification], etc., is a significant burden.”
Some participants noted that the environment for careers
in research is changing:
“The landscape has changed dramatically over my career.
Most importantly, it has become harder to obtain funding, but
almost as important, commitment to family has grown, in
part because the majority of our trainees and young faculty
are women, but also because this has become more important
to men. Thus, while there used to be an issue of balancing
time for research with time for clinical care and teaching,
there is now a greater issue of balancing time for family.
I think that this is a good thing, but it is nonetheless an
issue.”
With regard to facilitators, several participants noted that
successful researchers require all or many of the facilita-
tors listed:
“A successful young investigator needs to have ALL of the
things listed above. If a young investigator is missing ANY of
them (funding, time, mentorship, work ethic/passion, family
support), then they will fail.”
Figure 2. Facilitators of a career in research. Among all survey participants, the most commonly cited facilitators are shown for all par-
ticipants and then subgroups of participants. The x-axis shows the percentage of participants ranking each item as important (defined
as ranking the item as 1, 2, or 3 of 10). The facilitators are split into the following categories: F5 funding; J5 job duties; M5mentoring
and networking; O5 outside influences; I5 institution; P5personal skills and characteristics. Additional facilitators and P values for
differences between groups are shown in Supplementary Table 1 (available in the online version of this article at http://onlinelibrary.
wiley.com/doi/10.1002/acr.22569/abstract).
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Supporting young investigators and improving the
research environment. Participants were asked to give a
free-text answer to the question, “How can the ACR best sup-
port young investigators?” and a free-text space was avail-
able for additional open comments. A total of 632 comments
from the 2 items were reviewed. Content analysis revealed
numerous themes related to improving the research career
landscape for young investigators, many of which were
directed at efforts the ACR could pursue to improve support
for young investigators (Table 3). These responses were cate-
gorized as follows: funding, mentoring, career development
and skill building, increase interest in and sustainability of
research as a career, improve the research environment for
young investigators, and miscellaneous. Overall, partici-
pants were supportive of the ACR’s current endeavors:
“Continue the strong funding support options available
through the Rheumatology Research Foundation – these are
critical with the shrinking NIH portfolio.”
The most commonly reported theme was the need for
increased funding, particularly for young investigators,
but also increased pilot funding from the ACR extended to
diseases other than inflammatory arthritis and bridge
funding with attention to the K-to-R transition. Partici-
pants also suggested increasing the salary support from
grants, including federally funded grants:
“$75K for a K award is not sufficient to support a salary and
institutions do not provide money to support the gap. Thus,
K award holders spread themselves thin to get more grants to
provide salary support rather than spending the 75% pro-
tected time on the specific K award research project. Thus,
allowing for overlapping funds is important.”
Participants encouraged continuation and expansion of
advocacy efforts to increase NIH funding directed toward
rheumatic diseases:
“Advocacy for arthritis research funding at NIH.”
“Continued federal lobby[ing] to interest lawmakers in medi-
cal research – we are really not considered in any political
budget discussions.”
“. . .Highlight the potential benefits to be derived from
research. . .and the importance. . .in ultimately furthering the
field. The public needs to know, and perhaps become ener-
gized to help push for research dollars and support.”
The need for mentoring was the second most com-
monly reported theme. Participants suggested developing
a structured, cross-institutional mentoring program for
interested researchers and similarly to increase network-
ing for young investigators with experienced investiga-
tors. Furthermore, many participants also noted that
support for mentors is also important for the develop-
ment of young investigators.
“My primary concern is not direct support for the trainees
but rather the available pool of mentors – ever shrinking with
limited funding and the exodus of talented rheumatology
researchers away from academic medicine. So to me, in order
to adequately support trainees we need to make big steps to
facilitate the ability of ‘veteran’ researchers to remain intact.”
“If there are lapses in funding, then an entire career in aca-
demic medicine is lost, as institutions force faculty to either
leave or drop research altogether. Those of us who are still
standing are absolutely overwhelmed with mentoring respon-
sibilities, even as junior faculty, since there is a huge gap in
mid-level faculty who have left for practice or industry. We
are happy to do our research and mentor those after us, but
not if a single year of lapsed funding results in job loss.”
Other common themes included the need for develop-
ment of grant writing skills through workshops, webinars,
and mentorship; development of a community for young
investigators to provide peer mentoring; encouragement for
formal research training; development of standards for
research training in fellowship or a core research curricu-
lum; continued support for career development workshops;
collaboration among institutions; support for protected
time; and better compensation for investigators. Partici-
pants also suggested development of a loan repayment pro-
gram, early research exposure for medical students and
residents, and more comprehensive research exposure
early in fellowship. Finally, participants suggested that the
ACR should work with institutions to educate department
chairs, division chiefs, and fellowship directors about the
needs of young investigators and how to best support them
and provide support for young investigators from institu-
tions without strong research enterprises.
When asked which formats are best for presentation of
career development programs, workshops or seminars,
sessions at the ACR/ARHP Annual Meeting, mentoring
programs, and networking opportunities were selected by
more than one-half of the participants (Figure 3).
DISCUSSION
In this mixed-methods study, we report the perceived bar-
riers to and facilitators of a career in rheumatology research
among young investigators, fellows, mentors, established
investigators, and those who have left a career in research.
Our qualitative and quantitative results confirmed previous
findings that research funding is a major concern for inves-
tigators, particularly given increased competition for dwin-
dling NIH funding (2). However, protected research time,
protection from clinical duties, and mentorship frequently
ranked as important barriers and/or facilitators. Examina-
tion of reasons rheumatologists left research also revealed
the importance of institutional support.
To our knowledge, this is the first study to examine bar-
riers to and facilitators of a career as a physician-scientist
in the US from the perspectives of diverse constituencies,
including young investigators, mentors, fellows, and those
who decided to leave a career in research. Additionally,
this is the first study to examine reasons for leaving a
career in rheumatology research. Strengths of this study
include the development of survey items using the Delphi
technique and the relatively large number of responders
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Table 3. Themes derived from content analysis of free-text comments*
No. (%)
Funding 299 (70)
Early career and young investigator grants 62 (14)
Bridge funding (before K award, between K award and R01, or between R01s) 32 (7)
Pilot grants and smaller project funding 19 (4)
ACR should advocate for more federal funding 18 (4)
Need more federal funding 17 (4)
Loan repayment programs 14 (3)
Midcareer funding 13 (3)
Funds for research assistant or startup funds 11 (3)
Funding for non–US citizens 6 (1)
Increase salary support in grants 5 (1)
Partner with other organizations 5 (1)
Promote the success of rheumatology research (both ACR and NIAMS funded) 4 (1)
Find more donors 3 (1)
Career reentry awards 2 (0.5)
Mentoring 135 (31)
Develop structured mentoring networks 48 (11)
Fund and support mentors 16 (4)
Mentor training 6 (1)
Career development and skill building 211 (49)
Increase opportunities for networking 57 (13)
Grant writing support and/or workshops 44 (10)
Host programs and workshops for career development 41 (10)
Disseminate information about resources for young investigators, including funding
opportunities, job opportunities, research initiatives, research needs in the field using
the website, and interactive media, including webinars, online forums, and e-mail
distribution lists
21 (5)
Assist investigators with the K to R transition 20 (5)
Help young investigators develop their research focus and ideas 17 (4)
Support formal research training (e.g., masters programs) 16 (4)
Training in career skills such as presentation skills, leadership development, and
negotiation
14 (3)
Provide example career paths and assist in assessing career path 14 (3)
Create a community for young investigators 14 (3)
Specific training in research skills such as basic biostatistics, clinical trials training,
navigation of the research environment (e.g., IRBs, MTA), and research professionalism
(e.g., guidelines for authorship)
12 (3)
Support research fellowships and/or time in another laboratory 8 (2)
Encourage early participation in the ACR 8 (2)
Help individuals assess their own skills 5 (1)
Provide access to resources such as statistical support, data, etc. 3 (1)
Increase interest in and sustainability of research as a career 117 (27)
Increase research training in fellowship starting at the beginning of fellowship 31 (7)
More protected time 31 (7)
Better compensation 21 (5)
Provide early research experience for undergraduates, medical students, residents, and
fellows
20 (5)
Encourage cross-institutional collaboration 16 (4)
Salary security 15 (4)
Foster the development of the next generation of rheumatologists (both clinical and
research)
12 (3)
Nontraditional career paths to keep investigators in academics and research (e.g., part time
for parents with young children)
2 (1)
Improve the research environment for young investigators 71 (17)
Support clinicians who in turn can help support research 25 (6)
Support young investigators from institutions without solid research infrastructure and mentors 14 (3)
Educate division chiefs and fellowship directors about how best to support young
investigators
10 (2)
Provide advice or mediation for young investigators in conflict situations 4 (1)
Improve study sections at NIH 4 (1)
* ACR5American College of Rheumatology; NIAMS5National Institute of Arthritis and Musculoskeletal and Skin Diseases;
IRB5 institutional review board; MTA5Material Transfer Agreement; NIH5National Institutes of Health.
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(albeit a small proportion of the ACR), many of which pro-
vided very detailed and specific comments.
The Early Career Section of the American College of
Cardiology recently conducted a similar survey of early
career academicians in their field and found very similar
results to those presented in our study, including insuffi-
cient funding, clinical workload, and lack of institutional
commitment as major barriers to a career in research (5). A
handful of other studies have indicated funding (5–7),
mentoring (5,6,8,9), clinical workload and focus on clini-
cal productivity (5,7,10), lack of protected time (5,11), eco-
nomic disadvantage to a career in research (5,10,11), lack
of institutional support and resources (5,6,10), organiza-
tional problems (7), lack of availability of collaborators (5),
lack of support for women (7), personal attributes (6), and
concerns about career sustainability (9) are influential in
pursing or maintaining research careers.
Attracting rheumatology fellows into a career in research
is also important. A study by the ACR Young Investigators
Committee in 2009 examined rheumatology fellows’ per-
ceptions of a career in research and demonstrated the fel-
lows view a research career path as “high risk” (12).
Fellows noted barriers to an academic rheumatology career
path focused on funding issues, including decreased federal
funding for research, increasing competition for foundation
funding, and tightening budgets at academic institutions,
but also concerns about the incompatibility of family life
and academia. The latter concern about incompatibility
with family life is a particular concern given the increasing
number of women in rheumatology (3,13). Previous studies
have suggested that effective mentorship is particularly
important for the career development of women (14).
Limitations of our study include potential responder
bias, low response rate, bias in item selection, and misin-
terpretation of survey questions. As with all surveys, there
may be responder bias, particularly in this case, as more
investigators than clinicians and more academicians than
non-academic rheumatologists responded. It may be that
those who responded were more likely to have strong
opinions. Similarly, some participants could have partici-
pated more than once and, given the anonymity of partici-
pants, we may have missed some duplicates. We excluded
responses in which the demographics were identical and
the comments were nearly identical. Next, in building the
items for the survey, we performed a Delphi exercise
among the Early Career Investigator Subcommittee, all of
whom are assistant professors devoting the majority of
their time to research. This may have biased the results
obtained. Additionally, question order or grouping may
have influenced answer selection. We addressed these
risks by seeking additional comments.
Participants noted several potential solutions to the
mentioned barriers, including 1) development of a formal
cross-institutional mentoring network; 2) lobbying for
increased NIH funding; 3) working with institutions to
educate division chiefs and fellowship directors on the
needs of young investigators; 4) providing more career
development training, including topics such as grant writ-
ing, how to be a mentee, providing example career paths
and assistance in developing career development plans,
Figure 3. Formats most useful for presentation of career development and research training
initiatives. Participants were asked to select formats for presentation of information relevant
to career development and research training for young investigators. Young investigators and
mentors identified similar formats as being useful, except that young investigators more often
selected web-based formats compared to mentors. ACR5American College of Rheumatology.
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balancing clinical duties and research activities, develop-
ing collaborations, time management, and skill-based
training; and 5) creation of a list serve or community for
young investigators to network and share common experi-
ences and advice. Additional solutions suggested by other
studies include potential changes to NIH funding mecha-
nisms such as reinstitution of a specific R award for K
awardees attempting to achieve R funding for the first
time (15), institutional support in the way of childcare
services and mentoring for individuals struggling with
work–life balance (13), creating and seeking new funding
mechanisms through partnerships with industry and non-
profit organizations (5), and increasing research opportu-
nities during fellowship (5).
In summary, in order to attract young investigators into
rheumatology research and sustain their careers, knowl-
edge of the obstacles faced and the elements that facilitate
career persistence are critical. This study revealed that
funding and mentoring are the two greatest resources for
young investigators, but that numerous other factors play
a role in the development and sustenance of an investiga-
tor. Protection from excessive clinical and administrative
duties is also important particularly early in the investiga-
tor’s career, when he or she is gaining the necessary skills
to facilitate success. Many of the barriers and facilitators
identified are dependent on institution-specific resources
and personal characteristics and situations. However,
informing young investigators about how to locate and
leverage such resources and how to find support for indi-
vidual circumstances may improve the landscape for
young investigators. Improved and more wide-reaching
mentoring could potentially have a large impact on some
of the barriers noted. In partnership with the Childhood
Arthritis and Rheumatology Research Alliance (CARRA),
the ACR developed the ACR/CARRA Mentoring Interest
Group (AMIGO), a novel program aimed at matching pedi-
atric rheumatology fellows and junior faculty with men-
tors of similar interests at other institutions (16). This
model has been successful and could potentially be
expanded to include adult rheumatologists. With that
being said, participants recognized that mentors need pro-
tected time, funding, and recognition for their efforts (17).
As the American medical system continues to evolve in
the next decade, the challenges facing young investigators
will likewise evolve. The ACR has made support for
young investigators a significant part of their mission. A
continued effort to address and meet the needs of young
investigators and established investigators who serve as
their mentors is critical to maintaining the physician-
scientist workforce in rheumatology and supporting
advancements in our understanding of the etiology and
optimal treatment of the rheumatic diseases.
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